Tempest Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tempest Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2011 to Q3 2024.
  • Tempest Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$10.6M, a 55.6% decline year-over-year.
  • Tempest Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$35.5M, a 14.2% decline year-over-year.
  • Tempest Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.5M, a 17.4% increase from 2022.
  • Tempest Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$35.7M, a 26.2% decline from 2021.
  • Tempest Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$28.3M, a 47.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$35.5M -$10.6M -$3.77M -55.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$31.7M -$9.57M -$1.99M -26.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$29.8M -$7.9M -$268K -3.51% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$29.5M -$7.49M +$1.62M +17.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$31.1M -$6.79M +$2.16M +24.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$33.3M -$7.58M +$1.59M +17.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$34.9M -$7.64M +$855K +10.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$35.7M -$9.1M +$19.2M +67.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$54.9M -$8.95M -$837K -10.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$54.1M -$9.17M -$2.11M -29.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$52M -$8.49M -$3.14M -58.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$48.8M -$28.3M -$31.8M -920% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-29
Q3 2021 -$17.1M -$8.11M -$2.68M -49.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$14.4M -$7.06M -$1.83M -35% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$12.6M -$5.36M +$6.64M +55.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$19.2M $3.45M +$16.1M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$35.4M -$5.43M +$6.2M +53.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$41.6M -$5.23M +$4.64M +47% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$46.2M -$12M -$1.63M -15.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$44.6M -$12.7M -$2.15M -20.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$42.4M -$11.6M -$4.1M -54.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$38.3M -$9.87M -$5.03M -104% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$33.3M -$10.4M -$6.11M -143% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$27.2M -$10.5M +$31.6M +75% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$58.8M -$7.54M +$1.83M +19.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$60.6M -$4.85M +$13.3M +73.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$73.9M -$4.26M +$10.6M +71.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$84.6M -$42.1M -$19.5M -86.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$65.1M -$9.37M +$9.92M +51.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$75M -$18.2M +$382K +2.06% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$75.4M -$14.9M +$6.86M +31.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$82.3M -$22.6M -$2.04M -9.91% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$80.2M -$19.3M -$1.37M -7.64% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$78.8M -$18.6M -$1.08M -6.16% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$77.8M -$21.8M -$4.55M -26.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$73.2M -$20.6M -$1.71M -9.06% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 -$71.5M -$17.9M -$5M -38.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$66.5M -$17.5M -$7.6M -76.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$58.9M -$17.2M -$9.39M -120% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$49.5M -$18.9M -$7.89M -71.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 -$41.6M -$12.9M -$6.03M -87.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$35.6M -$9.89M -$3.9M -65% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$31.7M -$7.81M -$2.66M -51.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$29M -$11M -$6.81M -162% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$22.2M -$6.89M -$3.77M -121% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$18.5M -$6M -$2.76M -85.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$15.7M -$5.16M -$2.19M -73.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$13.5M -$4.19M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$3.12M -$2.34M -303% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$3.23M -$2.82M -689% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$2.97M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 -$774K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$410K Apr 6, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.